BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27477265)

  • 1. Prospective Prediction of Antitarget Activity by Matched Molecular Pairs Analysis.
    Warner DJ; Bridgland-Taylor MH; Sefton CE; Wood DJ
    Mol Inform; 2012 May; 31(5):365-8. PubMed ID: 27477265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationship models of chemical transformations from matched pairs analyses.
    Beck JM; Springer C
    J Chem Inf Model; 2014 Apr; 54(4):1226-34. PubMed ID: 24605924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR-assisted-MMPA to expand chemical transformation space for lead optimization.
    Fu L; Yang ZY; Yang ZJ; Yin MZ; Lu AP; Chen X; Liu S; Hou TJ; Cao DS
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33418563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Silico Extraction of Design Ideas Using MMPA-by-QSAR and its Application on ADME Endpoints.
    Koutsoukas A; Chang G; Keefer CE
    J Chem Inf Model; 2019 Jan; 59(1):477-485. PubMed ID: 30497262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Application of Antitarget Activity Hotspots to Guide Compound Optimization.
    Hessler G; Matter H; Schmidt F; Giegerich C; Wang LH; Güssregen S; Baringhaus KH
    Mol Inform; 2011 Dec; 30(11-12):996-1008. PubMed ID: 27468154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process.
    Sushko Y; Novotarskyi S; Körner R; Vogt J; Abdelaziz A; Tetko IV
    J Cheminform; 2014; 6(1):48. PubMed ID: 25544551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semi-automated workflow for molecular pair analysis and QSAR-assisted transformation space expansion.
    Yang ZY; Fu L; Lu AP; Liu S; Hou TJ; Cao DS
    J Cheminform; 2021 Nov; 13(1):86. PubMed ID: 34774096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matched molecular pair analysis: significance and the impact of experimental uncertainty.
    Kramer C; Fuchs JE; Whitebread S; Gedeck P; Liedl KR
    J Med Chem; 2014 May; 57(9):3786-802. PubMed ID: 24738976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaustive Structure Generation for Inverse-QSPR/QSAR.
    Miyao T; Arakawa M; Funatsu K
    Mol Inform; 2010 Jan; 29(1-2):111-25. PubMed ID: 27463853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is molecular alignment an indispensable requirement in the MIA-QSAR method?
    Barigye SJ; Freitas MP
    J Comput Chem; 2015 Sep; 36(23):1748-55. PubMed ID: 26119527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the reliability of a QSAR model's predictions.
    He L; Jurs PC
    J Mol Graph Model; 2005 Jun; 23(6):503-23. PubMed ID: 15896992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched Molecular Pair Analysis in Drug Discovery: Methods and Recent Applications.
    Yang Z; Shi S; Fu L; Lu A; Hou T; Cao D
    J Med Chem; 2023 Apr; 66(7):4361-4377. PubMed ID: 37014039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design.
    Massarelli I; Macchia M; Minutolo F; Prota G; Bianucci AM
    Bioorg Med Chem; 2009 May; 17(10):3543-56. PubMed ID: 19398207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of compound potency changes in matched molecular pairs using support vector regression.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2014 Oct; 54(10):2654-63. PubMed ID: 25191787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
    Martin E; Mukherjee P
    J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
    Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
    Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR studies on BK channel activators.
    Coi A; Fiamingo FL; Livi O; Calderone V; Martelli A; Massarelli I; Bianucci AM
    Bioorg Med Chem; 2009 Jan; 17(1):319-25. PubMed ID: 19026552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.